BioSpace News Archive

Mersana Therapeutics, Inc., (Nasdaq:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the closing of its underwritten registered public offering of 9,200,000 shares

In response to Gov. Gavin Newsom’s declared state of emergency in Los Angeles County, Health Net, LLC is providing special assistance to ensure its members have access to essential prescription medications and other healthcare services to help them cope with grief, loss, stress or trauma.

The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic

Pac Roots Cannabis Corp., is pleased to announce the execution of a binding letter of intent to form Rock Creek Farms, a proposed 100 acre commercial hemp operation, slated for production this spring in Rock Creek, British Columbia.

Cleveland BioLabs, Inc., announced that it has entered into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of 1,515,878 shares of its common stock, at a purchase price of $2.0945 per share, in a registered direct offering priced at-the-market under Nasdaq rules.

Smart inhalers are increasingly becoming the preferred course of managing and treating respiratory diseases.

Urgent care center is a type of walk-in clinic that offers ambulatory care in a dedicated medical facility outside of a conventional emergency room. They are mainly used for treating illnesses or injuries that need immediate care, but do not warrant a visit to the ER.

Medical nonwoven disposables have become essential products in the healthcare industry.

Rigorous safety and quality laws thatcontrol the entire process of product certification and testing acrosspharmaceutical and biopharmaceutical industries are prognosticated to spell growth forglobal bioprocess validation market over the timeframe of stipulation.

Growing prevalence of zoonotic diseases is projected to boost demand for veterinary chemistry analyzer globally.